Art
J-GLOBAL ID:201102222573625067   Reference number:11A0842173

Oral Administration of Immunopotentiator from Pantoea agglomerans 1 (IP-PA1) Improves the Survival of B16 Melanoma-Inoculated Model Mice

Pantoea agglomerans 1(IP-PA1)からの免疫賦活物質の経口投与はB16黒色腫接種モデルマウスの生存率を改善する
Author (15):
Material:
Volume: 60  Issue:Page: 101-109 (J-STAGE)  Publication year: 2011 
JST Material Number: Z0755A  ISSN: 1341-1357  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0842173&from=J-GLOBAL&jstjournalNo=Z0755A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Basic research of immunotherapeutic agents and blood preparations  ,  Microorganism biochemistry 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (44):
  • ADOLF, G. R. Structure and effects of interferon-gamma. Oncology. 1985, 42, S33-S40
  • AEBERSOLD, P. Lysis of autologous melanoma cells by tumorinfiltrating lymphocytes : association with clinical response. J. Natl. Cancer Inst. 1991, 83, 932-937
  • AKIRA, S. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4, 499-511
  • ANGELE, M. K. Surgical trauma and immunosuppression : pathophysiology and potential immunomodulatory approaches. Langenbecks Arch. Surg. 2005, 390, 333-341
  • ATALLAH, E. Treatment of metastatic malignant melanoma. Curr. Treat. Options Oncol. 2005, 6, 185-193
more...

Return to Previous Page